ANX005 Results "Suggest a Potential Path Forward" - Needham & Company Reiterates Buy Rating, $24 Price Target on Annexon Biosciences (ANNX)
Tweet Send to a Friend
Needham & Company analyst Joseph Stringer reiterated a Buy rating and $24.00 price target on Annexon Biosciences (NASDAQ: ANNX), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
